Fig. 2From: Associations of maternal diet and nutritional status with offspring hepatic steatosis in the Avon longitudinal study of parents and childrenData flow chart for ALSPAC cohort analysis. Of the 10,018 ALSPAC participants invited to attend the Focus@24+ visit, 3877 had Fibroscan for hepatic steatosis measure performed. Of these, 3766 had a valid CAP score. After exclusions for twin pregnancies and those missing all four maternal exposures, the final sample size was 3353. 1No consent for liver scan, not eligible, or excluded due to active implant, liver ascites, or pregnancy. Abbreviations: CAP = controlled attenuation parameterBack to article page